We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Labopharm Inc. (MM) | NASDAQ:DDSS | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.14 | 0 | 01:00:00 |
Form 20-F
x
|
Form 40-F
o
|
Yes
o
|
No
x
|
Yes
o
|
No
x
|
Yes
o
|
No
x
|
Exhibit
|
Description
|
99.1
|
Second Amendment to Exclusive License Agreement between Labopharm Europe a wholly-owned subsidiary of the Registrant and Purdue Pharma Products L.P. dated as of December 31, 2010.
|
99.2 |
Third Amending Agreement to the Distribution and License Agreement between the Registrant and Paladin Labs Inc. effective as of October 13, 2010.
|
99.3 |
Amended and Restated Manufacturing, Packaging and Supply Services Agreement entered into amongst the Registrant and Confab Laboratories Inc. dated June 01, 2010.
|
99.4 |
Amended and Restated Manufacturing, Packaging and Supply Services Agreement entered into amongst the Registrant and Confab Laboratories Inc. dated June 01, 2010.
|
LABOPHARM INC.
|
|||
Date: March 31, 2011
|
By:
|
/s/ Mark A. D’Souza | |
Name: Mark A. D’Souza | |||
Title: President and Chief Executive Officer | |||
1 Year Labopharm Inc. (MM) Chart |
1 Month Labopharm Inc. (MM) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions